Losartan potassium and Neutrophil percentage increased - a phase IV clinical study of FDA data


Neutrophil percentage increased is reported only by a few people who take Losartan Potassium.

The phase IV clinical study analyzes which people take Losartan potassium and have Neutrophil percentage increased. It is created by eHealthMe based on reports of 40,425 people who have side effects while taking Losartan potassium from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

40,425 people reported to have side effects when taking Losartan potassium.
Among them, 4 people (0.01%) have Neutrophil percentage increased.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 41,812 Losartan potassium users for its effectiveness, alternative drugs and more.

What is Neutrophil percentage increased?

Neutrophil percentage increased is found to be associated with 807 drugs and 491 conditions by eHealthMe.

Number of Losartan potassium and Neutrophil percentage increased reports submitted per year:

Could Losartan potassium cause Neutrophil percentage increased?

Time on Losartan potassium when people have Neutrophil percentage increased *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Neutrophil percentage increased when taking Losartan potassium *:

  • female: 50 %
  • male: 50 %

Age of people who have Neutrophil percentage increased when taking Losartan potassium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Losartan potassium *:

  1. Simvastatin: 2 people, 50.00%
  2. Imuran: 2 people, 50.00%
  3. Amlodipine: 2 people, 50.00%
  4. Bactrim: 2 people, 50.00%
  5. Coumadin: 2 people, 50.00%
  6. Furosemide: 2 people, 50.00%
  7. Gabapentin: 2 people, 50.00%
  8. Acetaminophen: 2 people, 50.00%
  9. Metolazone: 2 people, 50.00%
  10. Omeprazole: 2 people, 50.00%

Common side effects people have besides Neutrophil percentage increased *:

  1. High Blood Cholesterol: 3 people, 75.00%
  2. Blood Glucose Increased: 3 people, 75.00%
  3. Prostate Cancer: 2 people, 50.00%
  4. Balanitis (inflammation of the glands penis): 2 people, 50.00%
  5. Lymphocyte Percentage Decreased: 2 people, 50.00%
  6. Blood Amylase Decreased: 2 people, 50.00%
  7. Blood Bicarbonate Increased: 2 people, 50.00%
  8. Blood Chloride Decreased: 2 people, 50.00%
  9. Ventricular Extrasystoles (premature cardiac contraction): 1 person, 25.00%
  10. Eosinophilia (eosinophil count in the peripheral blood exceeds): 1 person, 25.00%

Common conditions people have *:

  1. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 50.00%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 25.00%
  3. Diabetes: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and have Neutrophil percentage increased?

Check whether Neutrophil percentage increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Neutrophil percentage increased and when was it recovered:

Expand to all the drugs that have ingredients of losartan potassium:

Alternative drugs to, pros and cons of Losartan potassium:

Common Losartan potassium side effects:

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Neutrophil percentage increased treatments and more:

COVID vaccines that are related to Neutrophil percentage increased:

Common drugs associated with Neutrophil percentage increased:

All the drugs that are associated with Neutrophil percentage increased:

Common conditions associated with Neutrophil percentage increased:

All the conditions that are associated with Neutrophil percentage increased:

How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan potassium) and Losartan potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: